OBJECTIVE: The aim of this article is to summarize the recommended updates to the 2001 Stages of Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW + 10 reviewed advances in understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before and after the final menstrual period. METHODS: Scientists from five countries and multiple disciplines evaluated data from cohort studies of midlife women and in the context of chronic illness and endocrine disorders on change in menstrual, endocrine, and ovarian markers of reproductive aging including antimüllerian hormone, inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted by consensus. RESULTS: STRAW + 10 simplified bleeding criteria for the early and late menopausal transition, recommended modifications to criteria for the late reproductive stage (Stage -3) and the early postmenopause stage (Stage +1), provided information on the duration of the late transition (Stage -1) and early postmenopause (Stage +1), and recommended application regardless of women's age, ethnicity, body size, or lifestyle characteristics. CONCLUSIONS: STRAW + 10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts. Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making. Nonetheless, important knowledge gaps persist, and seven research priorities are identified.
OBJECTIVE: The aim of this article is to summarize the recommended updates to the 2001 Stages of Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW + 10 reviewed advances in understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before and after the final menstrual period. METHODS: Scientists from five countries and multiple disciplines evaluated data from cohort studies of midlife women and in the context of chronic illness and endocrine disorders on change in menstrual, endocrine, and ovarian markers of reproductive aging including antimüllerian hormone, inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted by consensus. RESULTS:STRAW + 10 simplified bleeding criteria for the early and late menopausal transition, recommended modifications to criteria for the late reproductive stage (Stage -3) and the early postmenopause stage (Stage +1), provided information on the duration of the late transition (Stage -1) and early postmenopause (Stage +1), and recommended application regardless of women's age, ethnicity, body size, or lifestyle characteristics. CONCLUSIONS:STRAW + 10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts. Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making. Nonetheless, important knowledge gaps persist, and seven research priorities are identified.
Authors: David M Robertson; Georgina E Hale; Damien Jolley; Ian S Fraser; Claude L Hughes; Henry G Burger Journal: J Clin Endocrinol Metab Date: 2008-10-14 Impact factor: 5.958
Authors: Nancy E Avis; Sarah Brockwell; John F Randolph; Shunhua Shen; Virginia S Cain; Marcia Ory; Gail A Greendale Journal: Menopause Date: 2009 May-Jun Impact factor: 2.953
Authors: Christine G Lee; Molly C Carr; Susan J Murdoch; Ellen Mitchell; Nancy F Woods; Mark H Wener; Wayne L Chandler; Edward J Boyko; John D Brunzell Journal: J Clin Endocrinol Metab Date: 2009-01-06 Impact factor: 5.958
Authors: Erik A H Knauff; Marinus J C Eijkemans; Cornelius B Lambalk; Marianne J ten Kate-Booij; Annemieke Hoek; Catharina C M Beerendonk; Joop S E Laven; Angelique J Goverde; Frank J M Broekmans; Axel P N Themmen; Frank H de Jong; Bart C J M Fauser Journal: J Clin Endocrinol Metab Date: 2008-12-09 Impact factor: 5.958
Authors: Wendy K Marsh; Joyce T Bromberger; Sybil L Crawford; Katherine Leung; Howard M Kravitz; John F Randolph; Hadine Joffe; Claudio N Soares Journal: Menopause Date: 2017-12 Impact factor: 2.953
Authors: MacKenzie R Peltier; José M Flores; Philip H Smith; Walter Roberts; Terril L Verplaetse; Kelly E Moore; Robyn Hacker; Lindsay M Oberleitner; Sherry A McKee Journal: Nicotine Tob Res Date: 2020-05-26 Impact factor: 4.244
Authors: Gwendolyn K Davis; Suttira Intapad; Ashley D Newsome; Laura E Coats; Daniel R Bamrick; Norma B Ojeda; Barbara T Alexander Journal: Hypertension Date: 2019-08-05 Impact factor: 10.190
Authors: Pangaja Paramsothy; Siobán D Harlow; Michael R Elliott; Lynda D Lisabeth; Sybil L Crawford; John F Randolph Journal: Menopause Date: 2013-07 Impact factor: 2.953